GILEAD SCIENCES, INC. Acquisitions, Net of Cash Acquired
GILEAD SCIENCES, INC. (GILD) reported Acquisitions, Net of Cash Acquired of $11.32 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-08-06
- GILEAD SCIENCES, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2026-06-30 was $11.21B, a 53276.19% increase year-over-year.
- GILEAD SCIENCES, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2026-03-31 was $109.00M, a 60.07% decline year-over-year.
- GILEAD SCIENCES, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2025-12-31 was $609.00M, a 712.00% increase year-over-year.
- GILEAD SCIENCES, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2025-09-30 was $167.00M, a 70.70% decline year-over-year.
- GILEAD SCIENCES, INC. payments to acquire businesses, net of cash acquired for fiscal 2025 was $1.07B, a 77.89% decline from fiscal 2024.
- GILEAD SCIENCES, INC. payments to acquire businesses, net of cash acquired for fiscal 2024 was $4.84B, a 320.14% increase from fiscal 2023.
- GILEAD SCIENCES, INC. payments to acquire businesses, net of cash acquired for fiscal 2023 was $1.15B, a 35.89% decline from fiscal 2022.
- GILEAD SCIENCES, INC. payments to acquire businesses, net of cash acquired for fiscal 2022 was $1.80B, a 13.45% increase from fiscal 2021.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 3 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.21B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $11.32B 10-Q · filed 2026-08-06 | $11.93B derived: sum of 3 quarters · filed 2026-08-06 | $12.09B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $109.00M 10-Q · filed 2026-05-07 | $718.00M derived: sum of 2 quarters · filed 2026-05-07 | $885.00M derived: sum of 3 quarters · filed 2026-05-07 | $906.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $609.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $776.00M derived: sum of 2 quarters · filed 2026-02-24 | $797.00M derived: sum of 3 quarters · filed 2026-08-06 | $1.07B 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $167.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $188.00M derived: sum of 2 quarters · filed 2026-08-06 | $461.00M 10-Q · filed 2025-11-07 | $536.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $294.00M 10-Q · filed 2026-08-06 | $369.00M derived: sum of 3 quarters · filed 2026-08-06 | $939.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $273.00M 10-Q · filed 2026-05-07 | $348.00M derived: sum of 2 quarters · filed 2026-05-07 | $918.00M derived: sum of 3 quarters · filed 2026-05-07 | $1.07B derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $75.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $645.00M derived: sum of 2 quarters · filed 2026-02-24 | $797.00M derived: sum of 3 quarters · filed 2026-02-24 | $4.84B 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $570.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $722.00M derived: sum of 2 quarters · filed 2025-11-07 | $4.76B 10-Q · filed 2025-11-07 | $5.04B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $152.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $4.20B 10-Q · filed 2025-08-07 | $4.47B derived: sum of 3 quarters · filed 2026-02-24 | $4.55B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $4.04B 10-Q · filed 2025-05-07 | $4.32B derived: sum of 2 quarters · filed 2026-02-24 | $4.40B derived: sum of 3 quarters · filed 2026-02-24 | $4.64B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $279.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $358.00M derived: sum of 2 quarters · filed 2026-02-24 | $601.00M derived: sum of 3 quarters · filed 2026-02-24 | $1.15B 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $79.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $322.00M derived: sum of 2 quarters · filed 2024-11-12 | $873.00M 10-Q · filed 2024-11-12 | $1.09B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $243.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $794.00M 10-Q · filed 2024-08-08 | $1.01B derived: sum of 3 quarters · filed 2025-02-28 | $1.46B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $551.00M 10-Q · filed 2024-05-08 | $769.00M derived: sum of 2 quarters · filed 2025-02-28 | $1.22B derived: sum of 3 quarters · filed 2025-02-28 | $1.54B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $218.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $666.00M derived: sum of 2 quarters · filed 2025-02-28 | $990.00M derived: sum of 3 quarters · filed 2025-02-28 | $1.80B 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $448.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $772.00M derived: sum of 2 quarters · filed 2023-11-07 | $1.58B 10-Q · filed 2023-11-07 | $1.62B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | $324.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $1.13B 10-Q · filed 2023-08-04 | $1.18B derived: sum of 3 quarters · filed 2024-02-23 | $1.26B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | $807.00M 10-Q · filed 2023-05-03 | $30.00M 10-Q · filed 2022-05-04 | $851.00M derived: sum of 2 quarters · filed 2024-02-23 | $934.00M derived: sum of 3 quarters · filed 2024-02-23 | $1.14B derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2021-12-31 | $44.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $127.00M derived: sum of 2 quarters · filed 2024-02-23 | $329.00M derived: sum of 3 quarters · filed 2024-02-23 | $1.58B 10-K · filed 2024-02-23 | $1.40B 10-K · filed 2022-02-23 | |||
| 2021-09-30 | $83.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $285.00M derived: sum of 2 quarters · filed 2022-11-02 | $1.54B 10-Q · filed 2022-11-02 | $1.40B 10-Q · filed 2021-11-03 | $21.66B derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | $202.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.46B 10-Q · filed 2022-08-08 | $1.35B 10-Q · filed 2021-08-05 | $21.57B derived: sum of 3 quarters · filed 2023-02-22 | $22.57B derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | $1.25B 10-Q · filed 2022-05-04 | $21.37B derived: sum of 2 quarters · filed 2023-02-22 | $22.37B derived: sum of 3 quarters · filed 2023-02-22 | $27.11B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $20.12B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $21.12B derived: sum of 2 quarters · filed 2023-02-22 | $25.86B derived: sum of 3 quarters · filed 2023-02-22 | $25.92B 10-K · filed 2023-02-22 | $25.74B 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $1.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $5.74B derived: sum of 2 quarters · filed 2021-11-03 | $5.80B 10-Q · filed 2021-11-03 | |||||
| 2020-06-30 | $4.74B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $4.80B 10-Q · filed 2021-08-05 | ||||||
| 2020-03-31 | $63.00M 10-Q · filed 2021-05-06 | |||||||
| 2019-12-31 | $4.25B 10-K · filed 2022-02-23 | $0.00 10-K · filed 2020-02-25 | ||||||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 | |||||||
| 2017-12-31 | $10.43B 10-K · filed 2020-02-25 | |||||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-26 | |||||||
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 | |||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $0.00 derived: sum of 2 quarters · filed 2016-02-24 | $0.00 derived: sum of 3 quarters · filed 2016-02-24 | $0.00 10-K · filed 2016-02-24 | ||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $0.00 derived: sum of 2 quarters · filed 2014-11-05 | $0.00 10-Q · filed 2014-11-05 | $355.00K derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $0.00 10-Q · filed 2014-08-04 | $355.00K derived: sum of 3 quarters · filed 2016-02-24 | $355.00K derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-07 | $355.00K derived: sum of 2 quarters · filed 2016-02-24 | $355.00K derived: sum of 3 quarters · filed 2016-02-24 | $355.00K derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2013-12-31 | $355.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $355.00K derived: sum of 2 quarters · filed 2016-02-24 | $355.00K derived: sum of 3 quarters · filed 2016-02-24 | $379.00M 10-K · filed 2016-02-24 | $378.64M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $0.00 derived: sum of 2 quarters · filed 2014-11-05 | $378.64M 10-Q · filed 2014-11-05 | $379.01M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $378.64M 10-Q · filed 2014-08-04 | $379.01M derived: sum of 3 quarters · filed 2015-02-25 | $379.01M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $378.64M 10-Q · filed 2014-05-07 | $379.01M derived: sum of 2 quarters · filed 2015-02-25 | $379.01M derived: sum of 3 quarters · filed 2015-02-25 | $379.01M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $364.00K derived: sum of 2 quarters · filed 2015-02-25 | $364.00K derived: sum of 3 quarters · filed 2015-02-25 | $10.75B 10-K · filed 2015-02-25 | $10.75B 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $0.00 derived: sum of 2 quarters · filed 2013-10-31 | $10.75B 10-Q · filed 2013-10-31 | $10.75B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $10.75B 10-Q · filed 2013-08-01 | $10.75B derived: sum of 3 quarters · filed 2014-02-25 | $10.75B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $10.75B 10-Q · filed 2013-05-08 | $10.75B derived: sum of 2 quarters · filed 2014-02-25 | $10.75B derived: sum of 3 quarters · filed 2014-02-25 | $11.12B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $0.00 derived: sum of 2 quarters · filed 2014-02-25 | $367.50M derived: sum of 3 quarters · filed 2014-02-25 | $588.61M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $367.50M derived: sum of 2 quarters · filed 2012-11-06 | $588.61M 10-Q · filed 2012-11-06 | $588.61M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $367.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | $588.61M 10-Q · filed 2012-08-01 | $588.61M derived: sum of 3 quarters · filed 2013-02-27 | |||||
| 2011-03-31 | $221.10M 10-Q · filed 2012-05-04 | $221.10M derived: sum of 2 quarters · filed 2013-02-27 | ||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $91.00M 10-K · filed 2013-02-27 | ||||||
| 2010-09-30 | $91.00M 10-Q · filed 2011-11-04 | |||||||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $0.00 derived: sum of 2 quarters · filed 2012-02-23 | $1.25B 10-K · filed 2012-02-23 | |||||
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $1.25B 10-Q · filed 2010-11-08 | ||||||
| 2009-06-30 | $1.25B 10-Q · filed 2010-08-09 | |||||||
| 2008-12-31 | $10.85M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $10.85M derived: sum of 2 quarters · filed 2011-02-28 | $10.85M 10-K · filed 2011-02-28 | |||||
| 2008-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $0.00 10-Q · filed 2009-11-05 | ||||||
| 2008-06-30 | $0.00 10-Q · filed 2009-08-05 | |||||||
| 2007-12-31 | $46.44M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |